Queen Mary University of London: clinical-trial pipeline
Queen Mary University of London is the sponsor of 256 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 76 are not yet finished and 3 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 182 |
| Phase 2 | 35 |
| Phase 3 | 14 |
| Phase 1 | 8 |
| Phase 4 | 7 |
| Early phase 1 | 4 |
| Phase 1/2 | 3 |
| Phase 2/3 | 3 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 147 |
| Recruiting | 51 |
| Active, not recruiting | 16 |
| Unknown | 12 |
| Withdrawn or not authorised | 12 |
| Not yet recruiting | 9 |
| Terminated | 9 |
Condition areas
| Area | Trials |
|---|---|
| Cardiovascular | 59 |
| Oncology | 50 |
| Infectious disease and vaccines | 29 |
| Nephrology and urology | 22 |
| Gastroenterology and liver | 19 |
| Respiratory | 19 |
| Neurology | 16 |
| Dermatology | 13 |
| Rare and genetic diseases | 12 |
| Metabolic and endocrine (diabetes, obesity) | 10 |
| Immunology and rheumatology | 9 |
| Musculoskeletal | 9 |
Countries
| Country | Trials |
|---|---|
| United Kingdom | 229 |
| Spain | 13 |
| Germany | 9 |
| France | 9 |
| Italy | 6 |
| Belgium | 5 |
| Hungary | 5 |
| Netherlands | 5 |
| Switzerland | 4 |
| Denmark | 4 |
| Ireland | 4 |
| Portugal | 4 |
| Zimbabwe | 4 |
| Australia | 3 |
| Finland | 3 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-07 | New trial posted | Identification of Lesion Characteristics in Coronary Plaques Using Multimodality Intravas… |
| 2026-10-07 | New trial posted | Predicting Plaque Growth Using Blood Flow Stress Markers: A Proof-of-Concept Study |
| 2026-09-02 | New trial posted | Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05498896 | Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC | Phase 2 | Active, not recruiting | Germany, Spain, United Kingdom |
| 2024-518244-20-01 | DISCUS: A Randomised Phase II Study Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenan… | Phase 2 | Active, not recruiting | Spain, France |
| 2024-511470-79-00 | The 3TR Molecular PAthobiology and PRecision Therapy iN EaRly Rheumatoid Arthritis Study | Phase 4 | Not yet recruiting | Belgium, Spain, Italy, Netherlands +1 |
| NCT06954480 | Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-nega… | Phase 2 | Recruiting | Germany, Spain, United Kingdom |
| NCT06276335 | Influence of Timing of Implant Placement on Early Healing Molecular Events | Not applicable | Recruiting | United Kingdom |
| NCT07165678 | CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2) | Not applicable | Recruiting | United Kingdom |
| NCT07498829 | Population Based Germline Testing for Early Detection and Prevention of Cancer | Not applicable | Recruiting | United Kingdom |
| NCT05208567 | London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardi… | Not applicable | Recruiting | United Kingdom |
| NCT06174948 | The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders | Not applicable | Recruiting | United Kingdom |
| NCT06340971 | Air Pollution and Pregnancy | Not applicable | Recruiting | United Kingdom |
| NCT04440761 | Barts-MINOCA Registry | Not applicable | Recruiting | United Kingdom |
| NCT07620730 | PrEP-LANA (Pre-exposure Prophylaxis- Long-acting Novel Antiviral Agent) | Not applicable | Not yet recruiting | |
| NCT06600438 | Slow-SPEED UK: A Double-Blind Randomised Feasibility Trial | Not applicable | Recruiting | United Kingdom |
| NCT06805136 | Establishing Social Connections in Urban Areas: Evaluating a Community-based Programme | Not applicable | Recruiting | United Kingdom |
| NCT04092660 | Increasing the Use of an Anti-snoring Mouth Guard (Mandibular Advancement Appliance) to Prevent Upper Airway… | Not applicable | Recruiting | United Kingdom |
| NCT06751706 | Detection of Mycobacterium Tuberculosis in Blood of TB Patients and Their Contacts in Uganda | Not applicable | Recruiting | Uganda |
| NCT07431021 | Children's Health, Respiratory Inflammation and Short-term Air Pollution | Not applicable | Recruiting | United Kingdom |
| NCT07013916 | Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatiti… | Not applicable | Recruiting | United Kingdom |
| NCT04695080 | ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis | Phase 2/3 | Active, not recruiting | United Kingdom |
| NCT07423338 | Monitoring Respiratory Muscle Function in Acute Respiratory Failure Patients on Non Invasive Respiratory Supp… | Not applicable | Recruiting | United Kingdom |
| NCT07864051 | Predicting Plaque Growth Using Blood Flow Stress Markers: A Proof-of-Concept Study | Not applicable | Recruiting | United Kingdom |
| NCT07716293 | Psychosocial Support for Nitrous Oxide Misuse | Not applicable | Not yet recruiting | United Kingdom |
| NCT06849245 | Εffectiveness of a Digital Social Intervention in Primary Care | Not applicable | Recruiting | United Kingdom |
| NCT06370273 | Thromboprophylaxis in Lower Limb Immobilisation | Phase 3 | Recruiting | United Kingdom |
| NCT07172425 | Evaluation of Adding Nitrate Into Foods for Regulating Nitric Oxide Bioavailability in Healthy Individuals | Not applicable | Recruiting | United Kingdom |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Queen Mary University of London clinical trials: 76 open, 17 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/queen-mary-university-of-london/, data as of 2026-10-25.